Related references
Note: Only part of the references are listed.Systematic review on the use of anticholinergic scales in poly pathological patients
Angela Ma Villalba-Moreno et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2016)
Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures
Lisa G. Pont et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study
Wan-Hsuan Lu et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Different methods, different results-how do available methods link a patient's anticholinergic load with adverse outcomes?
Tanja Mayer et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Anticholinergic burden in Parkinson's disease inpatients
Unax Lertxundi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Anticholinergic Medications and Risk of Community-Acquired Pneumonia in Elderly Adults: A Population-Based Case-Control Study
Kathleen J. Paul et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Confusion Regarding Anticholinergic Burden Measurement
Unax Lertxundi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Effect of Hospitalization on Inappropriate Prescribing in Elderly Medicare Beneficiaries
Brian C. Lund et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Comparison of Anticholinergic Risk Scales and Associations with Adverse Health Outcomes in Older People
Mohammed Saji Salahudeen et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Concordance Between Anticholinergic Burden Scales
Jennifer G. Naples et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
A New Elixhauser-based Comorbidity Summary Measure to Predict In-Hospital Mortality
Nicolas R. Thompson et al.
MEDICAL CARE (2015)
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2015)
Nursing home and end-of-life care in Parkinson disease
Delaram Safarpour et al.
NEUROLOGY (2015)
Physician response to a medication alert system in inpatients with levodopa-treated diseases
Marie Morris et al.
NEUROLOGY (2015)
Missing Dosages and Neuroleptic Usage May Prolong Length of Stay in Hospitalized Parkinson's Disease Patients
Daniel Martinez-Ramirez et al.
PLOS ONE (2015)
Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
Alison J. Yarnall et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
Mohammed Saji Salahudeen et al.
BMC GERIATRICS (2015)
Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia Number Needed to Harm
Donovan T. Maust et al.
JAMA PSYCHIATRY (2015)
Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study
Michal Lubomski et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period
Lisa-Ann Fraser et al.
ANNALS OF PHARMACOTHERAPY (2014)
Relative Mortality in U.S. Medicare Beneficiaries with Parkinson Disease and Hip and Pelvic Fractures
Marcie Harris-Hayes et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)
Anticholinergic Drug Use and Negative Outcomes Among the Frail Elderly Population Living in a Nursing Home
Francesco Landi et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Delirium and High Fever Are Associated with Subacute Motor Deterioration in Parkinson Disease: A Nested Case-Control Study
Atsushi Umemura et al.
PLOS ONE (2014)
Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale Results from the REPOSI Study
Luca Pasina et al.
DRUGS & AGING (2013)
Prevalence and Determinants of Anticholinergic Medication Use in Elderly Dementia Patients
Sneha D. Sura et al.
DRUGS & AGING (2013)
Comments on Duran et al.'s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3)
Unax Lertxundi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Systematic review of anticholinergic risk scales in older adults
Carlos E. Duran et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Expert-based drug lists to measure anticholinergic burden: similar names, different results
Unax Lertxundi et al.
PSYCHOGERIATRICS (2013)
Anticholinergic Drugs and Functional Outcomes in Older Patients Undergoing Orthopaedic Rehabilitation
Sejlo Koshoedo et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2012)
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
Helen C. Kales et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Predictors of Survival in Patients With Parkinson Disease
Allison W. Willis et al.
ARCHIVES OF NEUROLOGY (2012)
The prevalence, incidence and risk factors for delirium in Dutch nursing homes and residential care homes
Marijke Boorsma et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Delirium in hospitalized patients: Implications of current evidence on clinical practice and future avenues for researchuA systematic evidence review
Babar A. Khan et al.
JOURNAL OF HOSPITAL MEDICINE (2012)
Is there an increased risk of hip fracture in Parkinson's disease? A nationwide inpatient sample
Rajib K. Bhattacharya et al.
MOVEMENT DISORDERS (2012)
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study
K. F. Huybrechts et al.
BRITISH MEDICAL JOURNAL (2012)
The cholinergic system and Parkinson disease
Nicolaas I. Bohnen et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Drugs with anticholinergic properties: a current perspective on use and safety
Philip Gerretsen et al.
EXPERT OPINION ON DRUG SAFETY (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
The interplay of cholinergic function, attention, and falls in Parkinson's disease
Alison Yarnall et al.
MOVEMENT DISORDERS (2011)
Preventing Potentially Inappropriate Medication Use in Hospitalized Older Patients With a Computerized Provider Order Entry Warning System
Melissa L. P. Mattison et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
Uwe Ehrt et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries
Allison Wright Willis et al.
NEUROEPIDEMIOLOGY (2010)
Drug Burden Index Score and Functional Decline in Older People
Sarah N. Hilmer et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population The 3-City Study
Isabelle Carriere et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data
Carl van Walraven et al.
MEDICAL CARE (2009)
Inappropriate medication use and risk of falls – A prospective study in a large community-dwelling elderly cohort
Sarah Berdot et al.
BMC Geriatrics (2009)
Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease
Unax Lertxundi et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
The anticholinergic risk scale and anticholinergic adverse effects in older persons
James L. Rudolph et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Anticholinergic activity of 107 medications commonly used by older adults
Marci L. Chew et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
JM Miyasaki et al.
NEUROLOGY (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes
CL Wielinski et al.
MOVEMENT DISORDERS (2005)
Drugs with anticholinergic properties and cognitive performance in the elderly:: results from the PAQUID Study
N Lechevallier-Michel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Incidence of Parkinson's disease: Variation by age, gender, and Race/Ethnicity
SK Van Den Eeden et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study
D Aizenberg et al.
INTERNATIONAL PSYCHOGERIATRICS (2002)
Share Paper
